Can serum periostin predict bronchopulmonary dysplasia in premature infants?

Can serum periostin predict bronchopulmonary dysplasia in premature infants?

Background Bronchopulmonary dysplasia (BPD) is the most common morbidity complicating preterm birth and affects long-term respiratory outcomes. The objectives of this study were to establish whether serum periostin at birth, day of life (DOL) 28, and corrected 36 weeks’ gestational age could be pote...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric research 2022-10, Vol.92 (4), p.1108-1114
Hauptverfasser: Go, Hayato, Ono, Junya, Ohto, Hitoshi, Nollet, Kenneth E., Sato, Kenichi, Kume, Yohei, Maeda, Hajime, Chishiki, Mina, Haneda, Kentaro, Ichikawa, Hirotaka, Kashiwabara, Nozomi, Kanai, Yuji, Ogasawara, Kei, Sato, Maki, Hashimoto, Koichi, Nunomura, Satoshi, Izuhara, Kenji, Hosoya, Mitsuaki
Format: Artikel
Sprache:eng
Schlagworte:
Biomarkers
Birth Weight
Bronchopulmonary Dysplasia - diagnosis
Clinical Research Article
Female
Gestational age
Humans
Infant
Infant, Newborn
Infant, Premature
Infant, Premature, Diseases
Lung diseases
Medicine
Medicine & Public Health
Newborn babies
Pediatric Surgery
Pediatrics
Premature babies
Premature Birth
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background Bronchopulmonary dysplasia (BPD) is the most common morbidity complicating preterm birth and affects long-term respiratory outcomes. The objectives of this study were to establish whether serum periostin at birth, day of life (DOL) 28, and corrected 36 weeks’ gestational age could be potential biomarkers for BPD. Methods A total of 98 preterm Japanese infants born at 
ISSN:0031-3998
1530-0447
DOI:10.1038/s41390-021-01912-w